Press Release
<< Back
Generac Reports Fourth Quarter and Full-Year 2022 Results
Fourth Quarter 2022 Highlights
- Net sales decreased 2% to
$1.05 billion during the fourth quarter of 2022 as compared to$1.07 billion in the prior-year fourth quarter. Core sales, which excludes both the impact of acquisitions and foreign currency, decreased approximately 7%.- Residential product sales decreased 19% to
$575 million as compared to$706 million last year. - Commercial & Industrial (“C&I”) product sales increased 27% to
$361 million as compared to$284 million in the prior year.
- Residential product sales decreased 19% to
- Net income attributable to the Company during the fourth quarter was
$71 million , or$0.83 per share, as compared to$143 million , or$2.04 per share, for the same period of 2021. - Adjusted net income attributable to the Company, as defined in the accompanying reconciliation schedules, was
$113 million , or$1.78 per share, as compared to$162 million , or$2.51 per share, in the fourth quarter of 2021. - Adjusted EBITDA before deducting for noncontrolling interests, as defined in the accompanying reconciliation schedules, was
$174 million , or 16.6% of net sales, as compared to$220 million , or 20.7% of net sales, in the prior year. - Cash flow from operations was
$101 million as compared to$62 million in the prior year. Free cash flow, as defined in the accompanying reconciliation schedules, was$80 million as compared to$42 million for 2021. - The Company repurchased approximately 2.2 million shares of its common stock during the fourth quarter for
$222 million under its current share repurchase program. There is approximately$278 million remaining under the current share repurchase program as ofDecember 31, 2022 . - The Company is initiating its full-year 2023 net sales guidance to be a decline of approximately -6 to -10% as compared to the prior year on an as-reported basis, which includes approximately 1% of net favorable impact from acquisitions and foreign currency. Adjusted EBITDA margin, before deducting for non-controlling interests, is expected to be approximately 17.0 to 18.0%.
Full-Year 2022 Highlights
- Net sales increased 22% to a record
$4.56 billion during 2022 as compared to$3.74 billion in 2021. Core sales, which excludes both the impact of acquisitions and foreign currency, increased approximately 16%.- Residential product sales increased 19% to
$2.91 billion as compared to$2.46 billion last year. - C&I product sales grew 26% to
$1.26 billion as compared to$1.00 billion in the prior year.
- Residential product sales increased 19% to
- Net income attributable to the Company during 2022 was
$400 million , or$5.42 per share, as compared to$550 million , or$8.30 per share for 2021. - Adjusted net income attributable to the Company was
$539 million , or$8.33 per share, as compared to$619 million , or$9.63 per share, in 2021. - Adjusted EBITDA before deducting for noncontrolling interests, as defined in the accompanying reconciliation schedules, for 2022 was
$825 million , or 18.1% of net sales, as compared to$861 million , or 23.1% of net sales, last year. - Cash flow from operations was
$59 million as compared to$411 million in the prior year. Free cash flow, as defined in the accompanying reconciliation schedules, was$(24) million as compared to$306 million for 2021.
“Fourth quarter and full year 2022 results came in at the low end of our prior expectations due to continued softness in residential products,” said
Jagdfeld continued, “While we are experiencing temporary headwinds for home standby generators and clean energy products, the underlying secular growth themes and mega-trends that support our ‘Powering a Smarter World’ enterprise strategy remain firmly intact. We believe these growth drivers will support strong demand for backup power solutions for both homes and businesses well into the future. Additionally, we will continue to develop innovative energy technology solutions to participate in the significant growth opportunities that are presented by the evolution to the next generation grid.”
Additional Fourth Quarter 2022 Consolidated Highlights
Gross profit margin was 32.7% as compared to 34.0% in the prior-year fourth quarter. Unfavorable sales mix had a meaningful negative impact on gross margins, however this was partially offset by the favorable impact of previously implemented pricing actions.
Operating expenses increased
Provision for income taxes for the current year quarter was
Cash flow from operations was
Business Segment Results
Domestic Segment
Domestic segment total sales (including inter-segment sales, as disclosed in accompanying schedule) decreased 3% to
Adjusted EBITDA for the segment was
International Segment
International segment total sales (including inter-segment sales, as disclosed in accompanying schedule) increased 22% to
Adjusted EBITDA for the segment, before deducting for noncontrolling interests, was
2023 Outlook
The Company is initiating guidance for full-year 2023 consistent with comments provided on its third quarter earnings call on
Additionally, the Company expects net income margin, before deducting for non-controlling interests, to be approximately 7.5 to 8.5% for the full-year 2023. The corresponding adjusted EBITDA margin is expected to be approximately 17.0 to 18.0% and be disproportionately weighted toward the second half of the year.
Operating and free cash flow generation is expected to return to strong levels for the full year, with conversion of adjusted net income to free cash flow expected to be well over 100%.
Conference Call and Webcast
The conference call will also be webcast simultaneously on
Following the live webcast, a replay will be available on the Company’s website for 12 months.
About
Forward-looking Information
Certain statements contained in this news release, as well as other information provided from time to time by
Any such forward looking statements are not guarantees of performance or results, and involve risks, uncertainties (some of which are beyond the Company's control) and assumptions. Although
- frequency and duration of power outages impacting demand for our products;
- fluctuations in cost and quality of raw materials required to manufacture our products;
- availability of both labor and key components from our global supply chain, including single-sourced components, needed in producing our products;
- the possibility that the expected synergies, efficiencies and cost savings of our acquisitions will not be realized, or will not be realized within the expected time period;
- the risk that our acquisitions will not be integrated successfully;
- the impact on our results of possible fluctuations in interest rates, foreign currency exchange rates, commodities, product mix, logistics costs and regulatory tariffs;
- the duration and impact of the COVID-19 pandemic;
- difficulties we may encounter as our business expands globally or into new markets;
- our dependence on our distribution network;
- our ability to invest in, develop or adapt to changing technologies and manufacturing techniques;
- loss of our key management and employees;
- increase in product and other liability claims or recalls;
- failures or security breaches of our networks, information technology systems, or connected products;
- changes in environmental, health and safety, or product compliance laws and regulations affecting our products, operations, or customer demand;
- significant legal proceedings, claims, lawsuits or government investigations.
Should one or more of these risks or uncertainties materialize,
Any forward-looking statement made by
Non-GAAP Financial Metrics
Core Sales
The Company references core sales to further supplement
Adjusted EBITDA
To supplement our condensed consolidated financial statements presented in accordance with
Adjusted Net Income
To further supplement
Free Cash Flow
In addition, we reference free cash flow to further supplement
The presentation of this additional information is not meant to be considered in isolation of, or as a substitute for, results prepared in accordance with
SOURCE:
CONTACT:
Senior Vice President – Corporate Development & Investor Relations
(262) 506-6064
InvestorRelations@generac.com
Condensed Consolidated Statements of Comprehensive Income | ||||||||||||||||
( |
||||||||||||||||
(Unaudited) | ||||||||||||||||
Three Months Ended |
Year Ended |
|||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Net sales | $ | 1,049,232 | $ | 1,067,071 | $ | 4,564,737 | $ | 3,737,184 | ||||||||
Costs of goods sold | 706,065 | 704,532 | 3,042,733 | 2,377,102 | ||||||||||||
Gross profit | 343,167 | 362,539 | 1,522,004 | 1,360,082 | ||||||||||||
Operating expenses: | ||||||||||||||||
Selling and service | 107,570 | 89,577 | 496,260 | 319,020 | ||||||||||||
Research and development | 38,446 | 29,406 | 159,774 | 104,303 | ||||||||||||
General and administrative | 62,825 | 37,758 | 194,861 | 144,272 | ||||||||||||
Acquisition related costs | 1,459 | 12,668 | 1,459 | 21,465 | ||||||||||||
Amortization of intangibles | 25,639 | 17,649 | 103,320 | 49,886 | ||||||||||||
Total operating expenses | 235,939 | 187,058 | 955,674 | 638,946 | ||||||||||||
Income from operations | 107,228 | 175,481 | 566,330 | 721,136 | ||||||||||||
Other (expense) income: | ||||||||||||||||
Interest expense | (19,523 | ) | (9,529 | ) | (54,826 | ) | (32,953 | ) | ||||||||
Investment income | 509 | 403 | 1,129 | 1,415 | ||||||||||||
Loss on extinguishment of debt | – | – | (3,743 | ) | (831 | ) | ||||||||||
Other, net | (755 | ) | 223 | (424 | ) | 2,759 | ||||||||||
Total other expense, net | (19,769 | ) | (8,903 | ) | (57,864 | ) | (29,610 | ) | ||||||||
Income before provision for income taxes | 87,459 | 166,578 | 508,466 | 691,526 | ||||||||||||
Provision for income taxes | 13,568 | 20,616 | 99,596 | 134,957 | ||||||||||||
Net income | 73,891 | 145,962 | 408,870 | 556,569 | ||||||||||||
Net income attributable to noncontrolling interests | 2,876 | 3,067 | 9,368 | 6,075 | ||||||||||||
Net income attributable to |
$ | 71,015 | $ | 142,895 | $ | 399,502 | $ | 550,494 | ||||||||
Other comprehensive income (loss): | ||||||||||||||||
Foreign currency translation adjustment | 56,424 | (4,559 | ) | (48,841 | ) | (41,030 | ) | |||||||||
Net unrealized gain (loss) on derivatives | (1,120 | ) | 5,345 | 38,494 | 20,529 | |||||||||||
Other comprehensive income (loss) | 55,304 | 786 | (10,347 | ) | (20,501 | ) | ||||||||||
Total comprehensive income | 129,195 | 146,748 | 398,523 | 536,068 | ||||||||||||
Comprehensive income attributable to noncontrolling interests | 6,764 | 2,964 | 11,179 | 5,496 | ||||||||||||
Comprehensive income attributable to |
$ | 122,431 | $ | 143,784 | $ | 387,344 | $ | 530,572 | ||||||||
Net income attributable to common shareholders per common share - basic: | $ | 0.84 | $ | 2.09 | $ | 5.55 | $ | 8.51 | ||||||||
Weighted average common shares outstanding - basic: | 62,370,769 | 62,992,455 | 63,117,007 | 62,686,001 | ||||||||||||
Net income attributable to common shareholders per common share - diluted: | $ | 0.83 | $ | 2.04 | $ | 5.42 | $ | 8.30 | ||||||||
Weighted average common shares outstanding - diluted: | 63,583,384 | 64,487,071 | 64,681,357 | 64,253,408 | ||||||||||||
Condensed Consolidated Balance Sheets | ||||||||
( |
||||||||
(Unaudited) | ||||||||
2022 | 2021 | |||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 132,723 | $ | 147,339 | ||||
Accounts receivable, less allowance for credit losses of |
522,458 | 546,466 | ||||||
Inventories | 1,405,384 | 1,089,705 | ||||||
Prepaid expenses and other assets | 121,783 | 64,954 | ||||||
Total current assets | 2,182,348 | 1,848,464 | ||||||
Property and equipment, net | 467,604 | 440,852 | ||||||
Customer lists, net | 206,987 | 238,722 | ||||||
Patents and technology, net | 454,757 | 492,473 | ||||||
Other intangible assets, net | 41,719 | 66,436 | ||||||
Tradenames, net | 227,251 | 243,531 | ||||||
1,400,880 | 1,409,674 | |||||||
Deferred income taxes | 12,746 | 15,740 | ||||||
Operating lease and other assets | 175,170 | 121,888 | ||||||
Total assets | $ | 5,169,462 | $ | 4,877,780 | ||||
Liabilities and stockholders’ equity | ||||||||
Current liabilities: | ||||||||
Short-term borrowings | $ | 48,990 | $ | 72,035 | ||||
Accounts payable | 446,050 | 674,208 | ||||||
Accrued wages and employee benefits | 45,741 | 72,060 | ||||||
Accrued product warranty | 89,141 | 59,052 | ||||||
Other accrued liabilities | 349,389 | 272,622 | ||||||
Current portion of long-term borrowings and finance lease obligations | 12,733 | 5,930 | ||||||
Total current liabilities | 992,044 | 1,155,907 | ||||||
Long-term borrowings and finance lease obligations | 1,369,085 | 902,091 | ||||||
Deferred income taxes | 125,691 | 205,964 | ||||||
Operating lease and other long-term liabilities | 312,916 | 341,681 | ||||||
Total liabilities | 2,799,736 | 2,605,643 | ||||||
Redeemable noncontrolling interest | 110,471 | 58,050 | ||||||
Stockholders’ equity: | ||||||||
Common stock, par value |
728 | 725 | ||||||
Additional paid-in capital | 1,016,138 | 952,939 | ||||||
(808,491 | ) | (448,976 | ) | |||||
Excess purchase price over predecessor basis | (202,116 | ) | (202,116 | ) | ||||
Retained earnings | 2,316,224 | 1,965,957 | ||||||
Accumulated other comprehensive loss | (65,102 | ) | (54,755 | ) | ||||
Stockholders’ equity attributable to |
2,257,381 | 2,213,774 | ||||||
Noncontrolling interests | 1,874 | 313 | ||||||
Total stockholders’ equity | 2,259,255 | 2,214,087 | ||||||
Total liabilities and stockholders’ equity | $ | 5,169,462 | $ | 4,877,780 | ||||
Condensed Consolidated Statements of Cash Flows | ||||||||
( |
||||||||
(Unaudited) | ||||||||
Year Ended |
||||||||
2022 | 2021 | |||||||
Operating activities | ||||||||
Net income | $ | 408,870 | $ | 556,569 | ||||
Adjustment to reconcile net income to net cash (used in) provided by operating activities: | ||||||||
Depreciation | 52,821 | 42,155 | ||||||
Amortization of intangible assets | 103,320 | 49,886 | ||||||
Amortization of original issue discount and deferred financing costs | 3,234 | 2,589 | ||||||
Loss on extinguishment of debt | 3,743 | 831 | ||||||
Deferred income taxes | (95,465 | ) | (2,096 | ) | ||||
Share-based compensation expense | 29,481 | 23,954 | ||||||
Gain on disposal of assets | (592 | ) | (4,393 | ) | ||||
Other noncash charges | 18,339 | 206 | ||||||
Net changes in operating assets and liabilities, net of acquisitions: | ||||||||
Accounts receivable | 6,547 | (131,861 | ) | |||||
Inventories | (319,274 | ) | (470,991 | ) | ||||
Other assets | 4,766 | (819 | ) | |||||
Accounts payable | (223,031 | ) | 297,323 | |||||
Accrued wages and employee benefits | (27,369 | ) | 5,814 | |||||
Other accrued liabilities | 110,036 | 73,798 | ||||||
Excess tax benefits from equity awards | (16,910 | ) | (31,809 | ) | ||||
Net cash provided by operating activities | 58,516 | 411,156 | ||||||
Investing activities | ||||||||
Proceeds from sale of property and equipment | 2,077 | 259 | ||||||
Proceeds from sale of investment | 1,308 | 4,968 | ||||||
Proceeds from beneficial interests in securitization transactions | 3,566 | 4,609 | ||||||
Contribution to equity method investment | (14,930 | ) | (3,660 | ) | ||||
Expenditures for property and equipment | (86,188 | ) | (109,992 | ) | ||||
Purchase of long-term investment | (15,000 | ) | – | |||||
Acquisition of business, net of cash acquired | (25,065 | ) | (713,471 | ) | ||||
Net cash used in investing activities | (134,232 | ) | (817,287 | ) | ||||
Financing activities | ||||||||
Proceeds from short-term borrowings | 248,209 | 272,818 | ||||||
Proceeds from long-term borrowings | 1,026,284 | 150,088 | ||||||
Repayments of short-term borrowings | (268,133 | ) | (239,113 | ) | ||||
Repayments of long-term borrowings and finance lease obligations | (542,191 | ) | (108,556 | ) | ||||
Stock repurchases | (345,840 | ) | (125,992 | ) | ||||
Payment of contingent acquisition consideration | (16,135 | ) | (3,750 | ) | ||||
Payment of debt issuance costs | (10,330 | ) | (1,185 | ) | ||||
Purchase of additional ownership interest | (375 | ) | (27,164 | ) | ||||
Cash dividends paid to noncontrolling interest of subsidiary | (309 | ) | – | |||||
Taxes paid related to equity awards | (40,923 | ) | (58,903 | ) | ||||
Proceeds from the exercise of stock options | 13,786 | 38,787 | ||||||
Net cash provided by (used in) financing activities | 64,043 | (102,970 | ) | |||||
Effect of exchange rate changes on cash and cash equivalents | (2,943 | ) | 1,312 | |||||
Net increase (decrease) in cash and cash equivalents | (14,616 | ) | (507,789 | ) | ||||
Cash and cash equivalents at beginning of period | 147,339 | 655,128 | ||||||
Cash and cash equivalents at end of period | $ | 132,723 | $ | 147,339 | ||||
Supplemental disclosure of cash flow information | ||||||||
Cash paid during the period | ||||||||
Interest | $ | 48,912 | $ | 27,842 | ||||
Income taxes | 150,893 | 156,728 | ||||||
Segment Reporting and Product Class Information | ||||||||||||||||||||||
( |
||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||
Total Sales by Reportable Segment | ||||||||||||||||||||||
Three Months Ended |
Three Months Ended |
|||||||||||||||||||||
External |
Intersegment Sales | Total Sales | External |
Intersegment Sales | Total Sales | |||||||||||||||||
Domestic | $ | 864,629 | $ | 15,989 | $ | 880,618 | $ | 896,402 | $ | 12,390 | $ | 908,792 | ||||||||||
International | 184,603 | 34,624 | 219,227 | 170,669 | 9,745 | 180,414 | ||||||||||||||||
Intercompany elimination | - | (50,613 | ) | (50,613 | ) | - | (22,135 | ) | (22,135 | ) | ||||||||||||
Total net sales | $ | 1,049,232 | $ | - | $ | 1,049,232 | $ | 1,067,071 | $ | - | $ | 1,067,071 | ||||||||||
Total Sales by Reportable Segment | ||||||||||||||||||||||
Year Ended |
Year Ended |
|||||||||||||||||||||
External |
Intersegment Sales | Total Sales | External |
Intersegment Sales | Total Sales | |||||||||||||||||
Domestic | $ | 3,867,866 | $ | 60,731 | $ | 3,928,597 | $ | 3,164,050 | $ | 39,339 | $ | 3,203,389 | ||||||||||
International | 696,871 | 93,699 | 790,570 | 573,134 | 26,123 | 599,257 | ||||||||||||||||
Intercompany elimination | - | (154,430 | ) | (154,430 | ) | - | (65,462 | ) | (65,462 | ) | ||||||||||||
Total net sales | $ | 4,564,737 | $ | - | $ | 4,564,737 | $ | 3,737,184 | $ | - | $ | 3,737,184 | ||||||||||
External |
||||||||||||||||||||||
Three Months Ended |
Year Ended |
|||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
Residential products | $ | 574,799 | $ | 705,808 | $ | 2,911,871 | $ | 2,456,765 | ||||||||||||||
Commercial & industrial products | 361,473 | 284,004 | 1,260,737 | 998,998 | ||||||||||||||||||
Other | 112,960 | 77,259 | 392,129 | 281,421 | ||||||||||||||||||
Total net sales | $ | 1,049,232 | $ | 1,067,071 | $ | 4,564,737 | $ | 3,737,184 | ||||||||||||||
Adjusted EBITDA | ||||||||||||||||||||||
Three Months Ended |
Year Ended |
|||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
Domestic | $ | 144,143 | $ | 196,691 | $ | 716,302 | $ | 795,417 | ||||||||||||||
International | 29,533 | 23,664 | 109,065 | 66,008 | ||||||||||||||||||
Total adjusted EBITDA (1) | $ | 173,676 | $ | 220,355 | $ | 825,367 | $ | 861,425 | ||||||||||||||
(1) See reconciliation of Adjusted EBITDA to Net income attributable to |
||||||||||||||||||||||
Reconciliation Schedules | |||||||||||||||||
( |
|||||||||||||||||
(Unaudited) | |||||||||||||||||
Net income to Adjusted EBITDA reconciliation | |||||||||||||||||
Three Months Ended |
Year Ended |
||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||
Net income attributable to |
$ | 71,015 | $ | 142,895 | $ | 399,502 | $ | 550,494 | |||||||||
Net income attributable to noncontrolling interests | 2,876 | 3,067 | 9,368 | 6,075 | |||||||||||||
Net income | 73,891 | 145,962 | 408,870 | 556,569 | |||||||||||||
Interest expense | 19,523 | 9,529 | 54,826 | 32,953 | |||||||||||||
Depreciation and amortization | 39,417 | 29,359 | 156,141 | 92,041 | |||||||||||||
Provision for income taxes | 13,568 | 20,616 | 99,596 | 134,957 | |||||||||||||
Non-cash write-down and other adjustments (1) | 7,934 | (3,708 | ) | (2,091 | ) | (3,070 | ) | ||||||||||
Non-cash share-based compensation expense (2) | 6,058 | 5,750 | 29,481 | 23,954 | |||||||||||||
Loss on extinguishment of debt (3) | - | - | 3,743 | 831 | |||||||||||||
Transaction costs and credit facility fees (4) | 1,195 | 12,886 | 5,026 | 22,357 | |||||||||||||
Business optimization and other charges (5) | 1,000 | (126 | ) | 4,371 | 33 | ||||||||||||
Provision for regulatory and clean energy product charges (6) | 10,000 | - | 65,265 | - | |||||||||||||
Other | 1,090 | 87 | 139 | 800 | |||||||||||||
Adjusted EBITDA | 173,676 | 220,355 | 825,367 | 861,425 | |||||||||||||
Adjusted EBITDA attributable to noncontrolling interests | 4,288 | 2,897 | 15,087 | 9,351 | |||||||||||||
Adjusted EBITDA attributable to |
$ | 169,388 | $ | 217,458 | $ | 810,280 | $ | 852,074 | |||||||||
(1) Includes gains/losses on disposals of assets and sales of certain investments, unrealized mark-to-market adjustments on commodity contracts, certain foreign currency related adjustments, and certain purchase accounting and contingent consideration adjustments. A full description of these and the other reconciliation adjustments contained in these schedules is included in |
|||||||||||||||||
(2) Represents share-based compensation expense to account for stock options, restricted stock and other stock awards over their respective vesting periods. | |||||||||||||||||
(3) Represents the write-off of original issue discount and capitalized debt issuance costs due to voluntary debt prepayment. | |||||||||||||||||
(4) Represents transaction costs incurred directly in connection with any investment, as defined in our credit agreement, equity issuance or debt issuance or refinancing, together with certain fees relating to our senior secured credit facilities. | |||||||||||||||||
(5) The current year period predominantly represents severance charges related to certain headcount reductions, as well as other restructuring charges related to the suspension of operations at certain of our facilities. | |||||||||||||||||
(6) The amount recorded in the third quarter 2022 represents a specific bad debt provision of |
|||||||||||||||||
Net income to Adjusted net income reconciliation | |||||||||||||||||
Three Months Ended |
Year Ended |
||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||
Net income attributable to |
$ | 71,015 | $ | 142,895 | $ | 399,502 | $ | 550,494 | |||||||||
Net income attributable to noncontrolling interests | 2,876 | 3,067 | 9,368 | 6,075 | |||||||||||||
Net income | 73,891 | 145,962 | 408,870 | 556,569 | |||||||||||||
Provision for income taxes (9) | - | 20,616 | - | 134,957 | |||||||||||||
Amortization of intangible assets | 25,639 | 17,649 | 103,320 | 49,886 | |||||||||||||
Amortization of deferred finance costs and original issue discount | 973 | 648 | 3,234 | 2,589 | |||||||||||||
Loss on extinguishment of debt (3) | - | – | 3,743 | 831 | |||||||||||||
Transaction costs and other purchase accounting adjustments (7) | 11,239 | 8,525 | 3,588 | 19,655 | |||||||||||||
(Gain)/loss attributable to business or asset dispositions (8) | - | (392 | ) | (229 | ) | (4,383 | ) | ||||||||||
Business optimization and other charges (5) | 1,000 | (126 | ) | 4,371 | 33 | ||||||||||||
Provision for regulatory and clean energy product charges (6) | 10,000 | – | 65,265 | – | |||||||||||||
Tax effect of add backs | (7,038 | ) | – | (43,638 | ) | – | |||||||||||
Cash income tax expense (9) | - | (29,667 | ) | - | (136,231 | ) | |||||||||||
Adjusted net income | 115,704 | 163,215 | 548,524 | 623,906 | |||||||||||||
Adjusted net income (loss) attributable to noncontrolling interests | 2,476 | 1,355 | 9,675 | 4,971 | |||||||||||||
Adjusted net income attributable to |
$ | 113,228 | $ | 161,860 | $ | 538,849 | $ | 618,935 | |||||||||
Adjusted net income attributable to |
$ | 1.78 | $ | 2.51 | $ | 8.33 | $ | 9.63 | |||||||||
Weighted average common shares outstanding - diluted: | 63,583,384 | 64,487,071 | 64,681,357 | 64,253,408 | |||||||||||||
(7) Represents transaction costs incurred directly in connection with any investment, as defined in our credit agreement, equity issuance or debt issuance or refinancing, and certain purchase accounting and contingent consideration adjustments. | |||||||||||||||||
(8) Represents gains and losses attributable to the disposition of a business or assets occurring in other than ordinary course, as defined in our credit agreement. | |||||||||||||||||
(9) Amount for the three months and year ended |
|||||||||||||||||
Free Cash Flow Reconciliation | |||||||||||||||||
Three Months Ended |
Year Ended |
||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||
Net cash (used in) provided by operating activities | $ | 100,868 | $ | 61,752 | $ | 58,516 | $ | 411,156 | |||||||||
Proceeds from beneficial interests in securitization transactions | 821 | 2,369 | 3,566 | 4,609 | |||||||||||||
Expenditures for property and equipment | (21,355 | ) | (22,536 | ) | (86,188 | ) | (109,992 | ) | |||||||||
Free cash flow | $ | 80,334 | $ | 41,585 | $ | (24,106 | ) | $ | 305,773 | ||||||||
Source: Generac Holdings Inc